The problems of anticholinergic adverse effects in older patients.
about
Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score)CUA guideline on adult overactive bladderThe effects of tolterodine on anterior segment and choroidal thickness in patients with overactive bladder syndrome.Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.Drug Burden Index in older adults: theoretical and practical issues.Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyEfficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.Mild cognitive impairment: an epidemiological perspective.Blood pressure normalization post-jugular venous balloon angioplastyConstipation as an adverse effect of drug use in nursing home patients: an overestimated risk.Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID StudyOcular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.An approach to drug induced delirium in the elderlyA new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD.Methods for assessing drug-related anticholinergic activity.The Influence of Patient Characteristics on Anticholinergic Events in Older People.Neurocognitive costs and benefits of psychotropic medications in older adults.Drug Burden Index and physical function in older Australian men.Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patientsPolypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.Drugs with anticholinergic properties: a current perspective on use and safety.Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.Identification and management of in-hospital drug-induced delirium in older patients.Anticholinergics for overactive bladder therapy: central nervous system effects.Secondary psychoses: an update.Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.Fever, immunity, and molecular adaptations.Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease.The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.Anticholinergics: theoretical and clinical overview.Management of lower urinary tract symptoms in Parkinson's disease in the neurology clinic.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine.Safety of inhaled long-acting anti-muscarinic agents in COPD.Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers.
P2860
Q28553063-EFA984F0-6797-47CE-8C00-D975E5411EB1Q33665026-ECB3501E-DA81-48A8-BEBE-7BD8F73CB858Q33727878-AAA3D0DF-4FB0-4C88-A582-F7C68DE292D4Q34093694-6B80C4CE-F4DD-4D5A-8279-139F868EA5B3Q34198674-2D2B337B-AB29-4054-A2BD-A7CDA6023FFCQ34407945-DC897816-7B42-4824-929F-155969B38E6CQ34900162-CCC127D9-F258-42E6-95C7-7C7C5E3CC7AAQ35236834-96BE4DA6-9F80-430B-8834-6BB52AACC51DQ35513272-8BBCEF3A-B818-4C8D-A849-AE858F4B9C38Q35802599-4BFA5E98-AA67-4979-B949-18A7D7E0CC36Q35826703-D6AF8806-73C2-4947-97A1-D177A98BCB08Q35826995-C6C9900D-3C6C-4A98-8E3B-2611363C99EAQ35836649-B2EE3D5F-75A3-4427-865D-9ACF00E77C5DQ35999260-F42711F1-04A0-4CD2-BA9C-FF67680784A5Q36289423-03C2E804-8D4B-4C47-AFA8-25C015E8E26AQ36650690-F935C4C1-1B88-47C0-B119-220B7786D083Q37001163-777A327C-5656-48F9-A162-956DC153C560Q37321432-F6C105C1-7B58-4CEA-AC2D-BD33B030AC72Q37399563-F5B45DF4-E566-4550-B550-3C46ADC768D7Q37466421-C602093A-F1A1-4E26-9395-E3BB18D0D7DDQ37632244-36F7A94C-6F14-403D-9008-A421B15EC79BQ37634389-7456996C-D0E6-4869-AAC6-D585D6CFD61FQ37879017-5091A4EA-638B-4969-9641-BCA91C288E51Q37884068-89664112-04F8-4EF4-B495-E99E716E5ACCQ37914849-812ADEA2-4E3F-48DE-83B8-872351E011E3Q37931232-AAABD67A-F599-43AB-AC57-4F60E591AE79Q37954372-82C95A4D-62E1-4326-89AB-7C705935CF14Q38087564-A2B20A60-2EDB-422E-A144-A1B9F468B7BEQ38150484-59A83E11-DECC-46AF-9046-FB350550510CQ38187907-382A3C5B-854A-46E8-A40B-6A11923A931FQ38201381-F31BDC25-0022-4D02-991B-72DDAAA9298BQ38223072-155B69B4-DD90-48F5-80EC-26168AF8436EQ38592062-A5EBC9E6-166A-40B7-B634-259221EDADCEQ38705840-A1892974-D729-440C-B706-26D3DF6C4518Q38769800-FE0F3DE0-86CE-4A90-AF11-6E3552C178C1Q38800103-0CC6DECA-8D58-4232-96D2-C55C55CF17F3Q38886942-297D6598-0BBB-4C77-A704-A9F27962618AQ39025277-99082A64-5B6B-45B6-A5A9-53562E2F7B35Q39232425-9A42A974-A1D2-46C2-92C4-D9A652D46CA0Q39250516-8D6B0DF3-12CC-47C0-B7EF-398DD43276E4
P2860
The problems of anticholinergic adverse effects in older patients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
The problems of anticholinergic adverse effects in older patients.
@en
type
label
The problems of anticholinergic adverse effects in older patients.
@en
prefLabel
The problems of anticholinergic adverse effects in older patients.
@en
P1433
P1476
The problems of anticholinergic adverse effects in older patients.
@en
P2093
M Feinberg
P304
P356
10.2165/00002512-199303040-00004
P577
1993-07-01T00:00:00Z
P6179
1015621468